Registration of securities issued in business combination transactions

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.23.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Series A
Convertible Redeemable Preferred Stock
Series B
Convertible Redeemable Preferred Stock
Special Voting Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2020 $ 20,405,219 $ 100 $ 94,088,323 $ (91,497) $ (57,179,525) $ 57,222,620
Balance at beginning (in Shares) at Dec. 31, 2020 2,667,349 995,062        
Conversion of exchangeable shares to common stock $ (18,039,181) $ 12 18,039,169
Conversion of exchangeable shares to common stock (in Shares) (2,358,063) 117,903        
Settlement of convertible notes $ 15 11,610,571 11,610,586
Settlement of convertible notes (in Shares) 154,706        
Shares withheld for withholding taxes $ (1) (520,394) (520,395)
Shares withheld for withholding taxes (in Shares) (6,089)        
Shares issued in connection with Viridian acquisition $ 5 6,187,995 6,188,000
Shares issued in connection with Viridian acquisition (in Shares) 51,550        
Shares issued in connection with asset purchase 300,000 300,000
Shares issued in connection with asset purchase (in Shares) 4,167        
Shares issued (returned) in connection with 365 Cannabis acquisition $ 18 11,996,043 11,996,061
Shares issued (returned) in connection with 365 Cannabis acquisition (in Shares) 178,572        
Stock-based compensation 2,070,358 2,070,358
Shares issued in connection with the ATM offering program $ 3 1,828,116 1,828,119
Shares issued in connection with the ATM offering program (in Shares) 27,819        
Liabilities with shares $ 1 430,024 430,025
Liabilities with shares (in Shares) 5,085        
Restricted stock vesting $ 2 (2)
Restricted stock vesting (in Shares) 21,386        
Forfeitures of restricted shares
Forfeitures of restricted shares (in Shares) (67)        
Foreign currency translation adjustments 53,020 53,020
Unrealized gain on convertible notes 100,000 100,000
Net loss (31,328,711) (31,328,711)
Balance at ending at Dec. 31, 2021 $ 2,366,038 $ 155 146,030,203 61,523 (88,508,236) 59,949,683
Balance at ending (in Shares) at Dec. 31, 2021 309,286 1,550,094        
Conversion of exchangeable shares to common stock     $ (18,620) 18,620
Conversion of exchangeable shares to common stock (in Shares)     (2,434) 122        
Settlement of convertible notes     $ 17 3,299,983 3,300,000
Settlement of convertible notes (in Shares)     169,843        
Shares withheld for withholding taxes     (5,615) (5,615)
Shares withheld for withholding taxes (in Shares)     (222)        
Shares returned in connection with acquisition     $ (1) (939,999) (940,000)
Shares returned in connection with acquisition (in Shares)     (13,988)        
Stock-based compensation     316,855 316,855
Issuance of common stock upon vesting of restricted stock units    
Issuance of common stock upon vesting of restricted stock units (in Shares)     2,174        
Liabilities with shares     45,066 45,066
Liabilities with shares (in Shares)     732        
Foreign currency translation adjustments     (33,800) (33,800)
Unrealized gain on convertible notes     101,000 101,000
Net loss     (21,952,893) (21,952,893)
Balance at ending at Mar. 31, 2022     $ 2,347,418 $ 171 148,765,113 128,723 (110,461,129) 40,780,296
Balance at ending (in Shares) at Mar. 31, 2022     306,852 1,708,755        
Balance at beginning at Dec. 31, 2021 $ 2,366,038 $ 155 146,030,203 61,523 (88,508,236) 59,949,683
Balance at beginning (in Shares) at Dec. 31, 2021 309,286 1,550,094        
Net loss               (51,518,840)
Balance at ending at Jun. 30, 2022     $ 2,227,619 $ 184 150,441,933 302,352 (140,027,076) 12,945,012
Balance at ending (in Shares) at Jun. 30, 2022     291,192 1,841,337        
Balance at beginning at Dec. 31, 2021 $ 2,366,038 $ 155 146,030,203 61,523 (88,508,236) 59,949,683
Balance at beginning (in Shares) at Dec. 31, 2021 309,286 1,550,094        
Conversion of exchangeable shares to common stock $ (180,647) 180,647
Conversion of exchangeable shares to common stock (in Shares) (23,614) 1,180        
Settlement of convertible notes $ 21 3,925,479 3,925,500
Settlement of convertible notes (in Shares) 207,427        
Shares withheld for withholding taxes (9,926) (9,926)
Shares withheld for withholding taxes (in Shares) (1,662)        
Shares issued (returned) in connection with 365 Cannabis acquisition $ (1) (939,999) (940,000)
Shares issued (returned) in connection with 365 Cannabis acquisition (in Shares) (13,988)        
Common shares and warrants issued in connection with unit offering, net of issue costs $ 217 9,178,744 9,178,961
Common shares and warrants issued in connection with unit offering, net of issue costs (in Shares) 2,173,913        
Stock-based compensation 843,693 843,693
Shares issued in connection with the ATM offering program $ 64 1,854,501 1,854,565
Shares issued in connection with the ATM offering program (in Shares) 642,956        
Issuance of convertible redeemable preferred stock, net of issue costs $ 3,435,600 $ 858,900
Issuance of convertible redeemable preferred stock, net of issue costs (in Shares) 400,000 100,000        
Deemed dividends related to convertible redeemable preferred stock $ 764,400 $ 191,100 (955,500) (955,500)
Deemed dividends related to convertible redeemable preferred stock (in Shares)        
Redemption of convertible redeemable preferred stock $ (4,200,000) $ (1,050,000)
Redemption of convertible redeemable preferred stock (in Shares) (400,000) (100,000)        
Liabilities with shares 49,529 49,529
Liabilities with shares (in Shares)     2,196        
Restricted stock vesting $ 2 49,998 50,000
Restricted stock vesting (in Shares)     20,282        
Fractional share adjustment from stock split $ 2 (2)
Fractional share adjustment from stock split (in Shares)     20,382        
Foreign currency translation adjustments 40,577 40,577
Unrealized gain on convertible notes 245,000 245,000
Net loss (79,057,610) (79,057,610)
Balance at ending at Dec. 31, 2022 $ 2,185,391 $ 460 160,207,367 347,100 (167,565,846) (4,825,528)
Balance at ending (in Shares) at Dec. 31, 2022 285,672 4,602,780        
Balance at beginning at Mar. 31, 2022     $ 2,347,418 $ 171 148,765,113 128,723 (110,461,129) 40,780,296
Balance at beginning (in Shares) at Mar. 31, 2022     306,852 1,708,755        
Conversion of exchangeable shares to common stock     $ (119,799) 119,799
Conversion of exchangeable shares to common stock (in Shares)     (15,660) 783        
Settlement of convertible notes     $ 4 625,496 625,500
Settlement of convertible notes (in Shares)       37,584        
Shares withheld for withholding taxes     (7,552) (7,552)
Shares withheld for withholding taxes (in Shares)       (337)        
Stock-based compensation     148,444 148,444
Issuance of common stock upon vesting of restricted stock units     25,000 25,000
Issuance of common stock upon vesting of restricted stock units (in Shares)       3,011        
Shares issued in connection with the ATM offering program     $ 9 761,169 761,178
Shares issued in connection with the ATM offering program (in Shares)       90,809        
Liabilities with shares     4,464 4,464
Liabilities with shares (in Shares)       732        
Foreign currency translation adjustments     10,629 10,629
Unrealized gain on convertible notes     163,000 163,000
Net loss     (29,565,947) (29,565,947)
Balance at ending at Jun. 30, 2022     $ 2,227,619 $ 184 150,441,933 302,352 (140,027,076) 12,945,012
Balance at ending (in Shares) at Jun. 30, 2022     291,192 1,841,337        
Balance at beginning at Dec. 31, 2022 $ 2,185,391 $ 460 160,207,367 347,100 (167,565,846) (4,825,528)
Balance at beginning (in Shares) at Dec. 31, 2022 285,672 4,602,780        
Conversion of exchangeable shares to common stock     $ (4,896) 4,896
Conversion of exchangeable shares to common stock (in Shares)     (640) 32        
Settlement of convertible notes     $ 116 1,396,985 1,397,101
Settlement of convertible notes (in Shares)     1,164,251        
Stock-based compensation     109,133 109,133
Issuance of common stock upon vesting of restricted stock units    
Issuance of common stock upon vesting of restricted stock units (in Shares)     587        
Foreign currency translation adjustments     20,429 20,429
Unrealized gain on convertible notes     (14,000) (14,000)
Net loss     (2,474,628) (2,474,628)
Balance at ending at Mar. 31, 2023     $ 2,180,495 $ 576 161,718,381 353,529 (170,040,474) (5,787,493)
Balance at ending (in Shares) at Mar. 31, 2023     285,032 5,767,650        
Balance at beginning at Dec. 31, 2022 $ 2,185,391 $ 460 160,207,367 347,100 (167,565,846) (4,825,528)
Balance at beginning (in Shares) at Dec. 31, 2022 285,672 4,602,780        
Net loss               (5,556,579)
Balance at ending at Jun. 30, 2023     $ 1,929,514 $ 700 162,692,715 337,103 (173,122,425) (8,162,393)
Balance at ending (in Shares) at Jun. 30, 2023     252,224 6,999,290        
Balance at beginning at Mar. 31, 2023     $ 2,180,495 $ 576 161,718,381 353,529 (170,040,474) (5,787,493)
Balance at beginning (in Shares) at Mar. 31, 2023     285,032 5,767,650        
Conversion of exchangeable shares to common stock     $ (250,981) $ 1 250,980
Conversion of exchangeable shares to common stock (in Shares)     (32,808) 1,640        
Settlement of convertible notes     $ 23 114,977 115,000
Settlement of convertible notes (in Shares)       230,000        
Stock-based compensation     108,477 108,477
Shares issued in a private placement offering     $ 100 499,900 500,000
Shares issued in a private placement offering (in Shares)       1,000,000        
Foreign currency translation adjustments     8,574 8,574
Unrealized loss on convertible notes     (25,000) (25,000)
Net loss     (3,081,951) (3,081,951)
Balance at ending at Jun. 30, 2023     $ 1,929,514 $ 700 $ 162,692,715 $ 337,103 $ (173,122,425) $ (8,162,393)
Balance at ending (in Shares) at Jun. 30, 2023     252,224 6,999,290